About
AptuCure Bio is developing AptuBodies, unique revolutionary synthetic aptamer-based nanoparticles mimicking antibody activity, that can be directed virtually against any target. An AptuBody binds non-covalently to the Fab fragment of circulating IgG antibody and thus provides the antibody a new antigen binding domain, targeted to a designed cell surface markers. An AptuBody will complex with any IgG, directing the complex to its target and activating safe natural complement-mediated immune response. The AptuBodies/IgG complex mimics therapeutic antibodies, by binding to cell surface antigens and promote activation of the natural immune system which aimed to kill the target cells, such as the complement system and killer cells. AptuBodies can replace humanized antibodies, for the treatment of cancer, infectious disease, and auto-immune disease.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is AptuCure Bio developing?
- AptuCure Bio is developing AptuBodies, which are synthetic aptamer-based nanoparticles designed to mimic antibody activity. These AptuBodies can be directed against various targets.
- What is the primary function of AptuBodies?
- AptuBodies bind non-covalently to the Fab fragment of circulating IgG antibodies, providing the antibody with a new antigen binding domain targeted to specific cell surface markers. This complex then activates a natural complement-mediated immune response.
- What medical conditions are AptuBodies intended to treat?
- AptuBodies are intended for the treatment of cancer, infectious diseases, and auto-immune diseases, potentially replacing humanized antibodies.
- When was AptuCure Bio founded?
- AptuCure Bio was founded in January 2015.
- Where is AptuCure Bio headquartered?
- AptuCure Bio is headquartered in Rehovot, Israel, at Prof. Efrayim Katzir Street 6.
- What is AptuCure Bio's current funding stage?
- AptuCure Bio is currently in the Pre-Funding stage, according to startupim data.
- How many employees does AptuCure Bio have?
- AptuCure Bio has 2 employees, falling into the 1-10 employees bucket.
- Who are the founders of AptuCure Bio?
- The founders of AptuCure Bio are Ofer Nussbaum, Ph.D., and Boaz Musafia.
- In which sector does AptuCure Bio primarily operate?
- AptuCure Bio primarily operates in the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
- Does AptuCure Bio hold any patents?
- Yes, AptuCure Bio holds 1 patent.